Briacell Inventory Turnover from 2010 to 2024

BCTX Stock  USD 0.53  0.03  5.54%   
Briacell Therapeutics Inventory Turnover yearly trend continues to be fairly stable with very little volatility. Inventory Turnover is likely to outpace its year average in 2024. Inventory Turnover is a ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management. View All Fundamentals
 
Inventory Turnover  
First Reported
2010-12-31
Previous Quarter
0.003252
Current Value
0.003414
Quarterly Volatility
4.4 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Briacell Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Briacell Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.7 K, Interest Expense of 0.0 or Other Operating Expenses of 34.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Days Sales Outstanding of 0.0 or Invested Capital of 622.1 K. Briacell financial statements analysis is a perfect complement when working with Briacell Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Briacell Therapeutics Correlation against competitors.

Latest Briacell Therapeutics' Inventory Turnover Growth Pattern

Below is the plot of the Inventory Turnover of Briacell Therapeutics Corp over the last few years. It is a ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management. Briacell Therapeutics' Inventory Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Briacell Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Inventory Turnover10 Years Trend
Very volatile
   Inventory Turnover   
       Timeline  

Briacell Inventory Turnover Regression Statistics

Arithmetic Mean(1,126,256,380)
Coefficient Of Variation(387.30)
Mean Deviation2,102,348,664
Median2.31
Standard Deviation4,361,979,303
Sample Variance19026863.4T
Range16.9B
R-Value(0.00000042)
Mean Square Error20490468.3T
R-Squared0
Significance1.00
Slope(408.18)
Total Sum of Squares266376088.1T

Briacell Inventory Turnover History

2024 0.003414
2023 0.003252
2021 0.003613
2020 0.0377
2019 0.0942
2018 2.31
2017-16.9 B

About Briacell Therapeutics Financial Statements

Briacell Therapeutics investors use historical fundamental indicators, such as Briacell Therapeutics' Inventory Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Briacell Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Briacell Stock Analysis

When running Briacell Therapeutics' price analysis, check to measure Briacell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Briacell Therapeutics is operating at the current time. Most of Briacell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Briacell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Briacell Therapeutics' price. Additionally, you may evaluate how the addition of Briacell Therapeutics to your portfolios can decrease your overall portfolio volatility.